Targeted Antibacterial Activity Guided by Bacteria-Specific Nitroreductase Catalytic Activation to Produce Ciprofloxacin
- 7 January 2019
- journal article
- research article
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 30 (3) , 751-759
Abstract
Fluoroquinolones (FQs) are among the front-line antibiotics used to treat severe infections caused by Gram-negative bacteria. However, recently, due to toxicity concerns, their use has been severely restricted. Hence, efforts to direct delivery of this antibiotic specifically to bacteria/site of infection are underway. Here, we report a strategy that uses a bacterial enzyme for activation of a prodrug to generate the active antibiotic. The ciprofloxacin-latent fluorophore conjugate 1, which is designed as a substrate for nitroreductase (NTR), a bacterial enzyme, was synthesized. Upon activation by NTR, release of Ciprofloxacin (CIP) as well as a fluorescence reporter was observed. We provide evidence for the prodrug permeating bacteria to generate a fluorescent signal and we found no evidence for activation in mammalian cells supporting selectivity of activation within bacteria. As a testament to its efficacy, 1 was found to have potent bactericidal activity nearly identical to CIP and significantly reduced the bacterial burden in a neutropenic mouse thigh infection model, again, at comparable potency with CIP, a clinically used FQ. Thus, together, we have developed a small molecule that facilitates bacteria-specific fluoroquinolone delivery.Keywords
Funding Information
- Council of Scientific and Industrial Research
- Department of Biotechnology , Ministry of Science and Technology (BT/PR15848/MED/29/1025/2016)
- Department of Science and Technology, Ministry of Science and Technology (EMR/2015/000668)
This publication has 61 references indexed in Scilit:
- Evaluation of a reducible disulfide linker for siderophore-mediated delivery of antibioticsJBIC Journal of Biological Inorganic Chemistry, 2018
- Global increase and geographic convergence in antibiotic consumption between 2000 and 2015Proceedings of the National Academy of Sciences, 2018
- Esterase-Catalyzed Siderophore Hydrolysis Activates an Enterobactin–Ciprofloxacin Conjugate and Confers Targeted Antibacterial ActivityJournal of the American Chemical Society, 2018
- GSH Induced Controlled Release of Levofloxacin from a Purpose-Built Prodrug: Luminescence Response for Probing the Drug Release inEscherichia coliandStaphylococcus aureusBioconjugate Chemistry, 2016
- Ciprofloxacin–Photoswitch Conjugates: A Facile Strategy for PhotopharmacologyBioconjugate Chemistry, 2015
- Nonantibiotic Effects of Fluoroquinolones in Mammalian CellsJournal of Biological Chemistry, 2015
- Syntheses and Antibacterial Activity of N-Acylated Ciprofloxacin Derivatives Based on the Trimethyl LockACS Medicinal Chemistry Letters, 2015
- Ciprofloxacin Affects Host Cells by Suppressing Expression of the Endogenous Antimicrobial Peptides Cathelicidins and Beta-Defensin-3 in Colon EpitheliaAntibiotics, 2014
- Risks associated with the therapeutic use of fluoroquinolonesExpert Opinion on Drug Safety, 2013
- A Prodrug Approach toward the Development of Water Soluble Fluoroquinolones and Structure−Activity Relationships of Quinoline-3-carboxylic AcidsJournal of Medicinal Chemistry, 2004